Concert for Cures is back at Petco Park on May 15. Artist will be announced in February. Sign up for early access here
Advancing Immune Checkpoint Inhibition of PSGL-1 for Treatment of Malignant Melanoma
Skin Cancer
Novel Approaches and New Therapeutic Platforms
Immunotherapies and Personalized Vaccines
Linda Bradley (SBP)
Soo Jin Park (UCSD)
Despite recent advances, malignant melanoma still causes thousands of deaths in the US each year. The goal of this project is to develop a novel, monoclonal antibody-based therapy that can reactivate the tumor-killing properties of the patient’s own immune system. This therapy has the potential to eradicate tumors that are refractory to existing therapy and thus save lives.
